Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$784K Sell
6,912
-6,801
-50% -$674K 0.19% 201
2026
Q1
$1.29M Buy
+13,713
New +$1.37M 0.31% 88
2025
Q2
Sell
-21,625
Closed -$1.31M 741
2025
Q1
$1.31M Buy
21,625
+9,411
+77% +$656K 0.39% 54
2024
Q4
$844K Buy
+12,214
New +$870K 0.19% 205
2024
Q2
Sell
-16,341
Closed -$931K 719
2024
Q1
$931K Buy
16,341
+12,533
+329% +$752K 0.24% 156
2023
Q4
$239K Sell
3,808
-6,575
-63% -$372K 0.17% 270
2023
Q3
$600K Buy
+10,383
New +$654K 0.34% 105
2023
Q2
Sell
-15,019
Closed -$1.09M 513
2023
Q1
$1.09M Buy
+15,019
New +$1.17M 0.35% 89

Other funds holding INCY

InceptionR's INCY Position: Q2 2026 in Review

InceptionR reduced its Incyte (INCY) stake by 50% in Q2 2026, selling an estimated $674K and leaving 6,912 shares worth $784K. The position accounts for 0.19% of the portfolio, ranked #201.

InceptionR first reported a position in INCY in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.31M in Q1 2025. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • InceptionR held 6,912 shares of Incyte worth $784K as of Q2 2026.
  • InceptionR sold 6,801 Incyte shares in Q2 2026, an estimated $674K.
  • Incyte made up 0.19% of InceptionR's portfolio in Q2 2026, its #201 holding.
  • InceptionR first reported a position in Incyte in Q1 2023 and has held it in 8 quarters since.
  • InceptionR's Incyte position peaked at $1.31M in Q1 2025.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.